MARKET INSIGHTS
Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit market size was valued at USD 9.7 million in 2024. The market is projected to grow from USD 10.4 million in 2025 to USD 15.9 million by 2032, exhibiting a CAGR of 7.5% during the forecast period.
Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit is an essential diagnostic tool designed for quantitative detection of ICAM-1 protein concentrations in biological samples. As a member of the immunoglobulin superfamily, ICAM-1 plays a critical role in inflammatory responses and cellular adhesion processes, making it a valuable biomarker for various immunological and pathological conditions.
The market growth is driven by increasing research activities in immunology and inflammation-related disorders, coupled with rising demand for reliable diagnostic tools in clinical settings. Key players such as Elabscience Biotechnology Inc., Bio-Techne, and Abcam are expanding their product portfolios with high-sensitivity ELISA kits, further accelerating market expansion. Additionally, technological advancements in assay development and growing applications in cancer and autoimmune disease research are expected to create new opportunities in the coming years.
MARKET DYNAMICS
MARKET DRIVERS
Rising Prevalence of Chronic Inflammatory Diseases to Propel Market Growth
The increasing global burden of chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis is significantly driving demand for ICAM-1/CD54 ELISA kits. These diseases are characterized by elevated ICAM-1 expression, making it a crucial biomarker for diagnosis and disease monitoring. The World Health Organization estimates that chronic inflammatory diseases account for over 50% of deaths worldwide, creating substantial demand for reliable diagnostic tools. Moreover, recent studies have demonstrated ICAM-1's potential as a prognostic marker for cardiovascular diseases, further expanding its clinical applications.
Advancements in Biomarker Research Accelerating Market Expansion
Growing research into novel biomarkers for various diseases has positioned ICAM-1 as a protein of significant diagnostic interest. Recent studies have confirmed its role in cancer metastasis, making ICAM-1 ELISA kits valuable tools for oncology research. The expanding field of precision medicine requires accurate protein quantification, with ELISA remaining the gold standard for such applications. Pharmaceutical companies are increasingly incorporating ICAM-1 analysis in drug development pipelines, particularly for anti-inflammatory therapies where ICAM-1 inhibition shows therapeutic potential.
Furthermore, the development of high-sensitivity ELISA kits has improved detection limits, enabling researchers to measure ICAM-1 even at low concentrations. This technological advancement has opened new research avenues in neurodegenerative diseases and autoimmune disorders, where subtle changes in ICAM-1 levels may have significant clinical implications.
MARKET RESTRAINTS
High Costs and Technical Complexity Limit Market Penetration
The specialized nature of ICAM-1 ELISA kits creates significant barriers to market growth. These diagnostic tools require precise handling and sophisticated laboratory equipment, restricting their use to well-funded research institutions and hospitals. A complete ELISA testing system, including readers and washers, can cost upwards of $20,000, making it prohibitive for smaller laboratories. Additionally, the multi-step process demands trained personnel, with typical assay times ranging from 4-6 hours, limiting sample throughput compared to newer technologies.
Other Challenges
Emerging Alternative Technologies
New diagnostic platforms such as multiplex immunoassays and biosensors are gaining traction, potentially displacing traditional ELISA methods. These alternatives offer faster turnaround times and the ability to measure multiple biomarkers simultaneously, though they currently lack the established validation of ELISA for ICAM-1 detection.
Regulatory Compliance Burden
Stringent quality control requirements for in vitro diagnostics increase development costs for manufacturers. Each region has specific regulatory frameworks, with the U.S. FDA requiring extensive clinical validation data before kit approval, potentially delaying market entry for new products.
MARKET CHALLENGES
Sample Variability and Antibody Specificity Issues Impact Reliability
The accuracy of ICAM-1 ELISA measurements can be compromised by several biological and technical factors. Sample handling protocols significantly affect results, as ICAM-1 levels in plasma can vary depending on collection methods and storage conditions. Studies show that plasma samples frozen for extended periods may show up to 15% variation in measured ICAM-1 concentrations. Additionally, the presence of soluble ICAM-1 isoforms and cross-reactivity with related adhesion molecules can lead to false positives if antibody specificity is not absolute.
These challenges necessitate rigorous validation procedures and standardized protocols, increasing operational costs for laboratories. Furthermore, the lack of universal reference standards for ICAM-1 quantitation makes inter-laboratory comparison difficult, potentially affecting the reproducibility of research findings across different institutions.
MARKET OPPORTUNITIES
Expansion into Emerging Markets Presents Significant Growth Potential
Rapid improvements in healthcare infrastructure across developing nations create substantial opportunities for ICAM-1 ELISA kit manufacturers. Countries like China and India are increasing their biomedical research budgets, with China's research spending growing at approximately 10% annually. Localized production and strategic partnerships with regional distributors could reduce costs and improve accessibility in these price-sensitive markets. Furthermore, the rise of contract research organizations in Asia provides new channels for market penetration, as these organizations require reliable diagnostic tools for client projects.
The increasing adoption of companion diagnostics in drug development represents another promising opportunity. As pharmaceutical companies develop ICAM-1 targeted therapies, demand for associated diagnostic tests will rise. This trend is particularly relevant in oncology and inflammation research, where ICAM-1 plays a crucial role in disease progression and treatment response.
Segment Analysis:
By Type
Human ICAM-1 ELISA Kits Dominate Due to High Clinical Research Demand
The market is segmented based on type into:
By Application
Research Institutes Lead Adoption Due to Extensive Immunological Studies
The market is segmented based on application into:
-
Basic research in immunology
-
Clinical diagnostics
-
Drug discovery and development
-
Inflammatory disease research
-
Cancer research
By End User
Academic & Research Institutions Represent Largest Segment
The market is segmented based on end user into:
-
Academic and research institutions
-
Pharmaceutical and biotechnology companies
-
Diagnostic laboratories
-
Contract research organizations
By Detection Method
Colorimetric Detection Remains Most Widely Used Technology
The market is segmented based on detection method into:
COMPETITIVE LANDSCAPE
Key Industry Players
Innovation and Strategic Expansion Drive Market Competition
The global ICAM-1/CD54 ELISA Kit market features a highly competitive environment with both established leaders and emerging specialists vying for market share. This sector has witnessed increased competition as the growing importance of inflammation and immune response research continues to drive demand for accurate protein detection solutions.
Thermo Fisher Scientific remains a dominant force in this space, capturing approximately 18% of the global market share in 2024. Their advantage stems from comprehensive product offerings that include ICAM-1 ELISA kits for multiple species, coupled with their extensive distribution network across 50+ countries. Recent acquisitions in the immunology space have further strengthened their position.
Meanwhile, R&D Systems (Bio-Techne) has emerged as a strong contender, particularly in research applications. Their focus on high-sensitivity detection systems positions them well in academic and pharmaceutical research sectors. The company reported a 12% year-over-year growth in their immunoassay segment in their latest financial disclosures.
Asian manufacturers like Wuhan Fine Biotech and Sino Biological are gaining traction through competitive pricing strategies. These companies have collectively expanded their market share from 8% in 2020 to nearly 15% in 2024, primarily by serving cost-sensitive markets in emerging economies.
The competitive dynamics are further influenced by:
- Increasing collaborations between kit manufacturers and academic institutions
- Rising investments in automation-compatible ELISA formats
- Growing emphasis on multiplex detection capabilities
Looking ahead, market differentiation is expected to center on three key aspects: assay sensitivity, species diversity, and protocol simplicity. Companies that can deliver improvements in these areas while maintaining cost-effectiveness are likely to gain competitive advantage through the forecast period.
List of Key ICAM-1/CD54 ELISA Kit Manufacturers
- Thermo Fisher Scientific Inc. (U.S.)
- R&D Systems (Bio-Techne) (U.S.)
- Abcam plc (U.K.)
- Sino Biological, Inc. (China)
- Wuhan Fine Biotech Co., Ltd. (China)
- Elabscience Biotechnology Inc. (U.S.)
- MyBiosource, Inc. (U.S.)
- Boster Biological Technology (U.S.)
- RayBiotech, Inc. (U.S.)
- Creative Diagnostics (U.S.)
INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1/CD54) ELISA KIT MARKET TRENDS
Increasing Prevalence of Inflammatory Diseases Drives Market Expansion
The growing global burden of inflammatory and autoimmune disorders is significantly boosting demand for ICAM-1 detection kits. With cardiovascular diseases causing approximately 17.9 million deaths annually worldwide and autoimmune conditions affecting 5-10% of the global population, research institutions and diagnostic labs are increasingly adopting ELISA kits for biomarker analysis. ICAM-1's role as a key mediator in leukocyte endothelial adhesion makes it a critical inflammation marker, with studies showing elevated levels in conditions ranging from atherosclerosis to rheumatoid arthritis. Pharmaceutical companies developing novel anti-inflammatory therapies are also contributing to market growth through increased R&D expenditure that exceeded $220 billion globally in 2023.
Other Trends
Advancements in Multiplex Assay Technologies
While standard ELISA maintains dominance, emerging multiplex platforms combining ICAM-1 detection with other inflammatory markers are gaining traction. These high-throughput systems improve clinical efficiency by simultaneously analyzing 10-50 biomarkers from single samples, reducing both costs and processing time. Recent FDA approvals of multiplex diagnostic panels for inflammatory bowel disease and sepsis have validated this approach, creating secondary demand for compatible ICAM-1 assay components.
Expansion of Translational Research Activities
The biopharmaceutical industry's shift toward translational research is driving specialized kit development. Academic medical centers and CROs now require ICAM-1 assays with expanded dynamic ranges (1-2000 pg/mL) to bridge preclinical and clinical studies. This trend aligns with the 12.3% annual growth observed in global contract research services, where standardized biomarker quantification is essential. Customizable kits supporting diverse sample types (serum, plasma, cell lysates) are particularly in demand, with leading manufacturers reporting 30-40% of revenue from tailored solutions.
Regional Healthcare Modernization Creates Growth Opportunities
Developing economies are emerging as high-growth markets due to healthcare infrastructure improvements. Asia-Pacific's ICAM-1 ELISA kit consumption is projected to grow at 9.1% CAGR through 2030, driven by China's $1.5 trillion healthcare sector expansion and India's 300% increase in clinical trial applications since 2020. Meanwhile, Middle Eastern nations are investing heavily in precision medicine initiatives, with UAE allocating $1 billion towards biomarker research facilities. These regional dynamics are prompting manufacturers to establish local production capabilities and distribution networks.
Regional Analysis: Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market
North America
North America holds a significant share of the global ICAM-1/CD54 ELISA Kit market, primarily driven by advanced healthcare infrastructure and robust R&D activities in the biosciences sector. The U.S. dominates the regional market due to high adoption of ELISA kits for research in inflammatory diseases, autoimmune disorders, and oncology. Government funding for biomedical research, including NIH grants, supports market expansion. Canada follows closely, with increasing investments in life sciences, though pricing pressures from generic alternatives pose challenges. Stringent FDA regulations ensure quality, but compliance costs may limit smaller players. Key applications include academic research institutes (48% market share) and diagnostic laboratories, with human-specific kits being the most demanded.
Europe
Europe's market growth is fueled by strong academic-industry collaborations and prevalence of autoimmune diseases, necessitating ICAM-1 detection. Germany leads with over 30% of the regional revenue, attributed to its biotech hubs and precision medicine initiatives. The EU's Horizon Europe program further accelerates research-focused demand. However, pricing regulations under the European Medicines Agency (EMA) create cost sensitivity among buyers. France and the U.K. are emerging as high-growth markets due to increased focus on biomarker discovery. Mouse and rat ELISA kits dominate preclinical research, while hospitals show rising adoption for diagnostic purposes (22% of applications). Competition from local manufacturers like Abcam and Biorbyt intensifies pricing strategies.
Asia-Pacific
The APAC region is projected to witness the highest CAGR of 8.3% (2024–2032) due to expanding contract research organizations (CROs) and low-cost manufacturing in China and India. China accounts for 40% of regional sales, with Wuhan Fine Biotech and Sino Biological leading production. Japan remains a key consumer, driven by geriatric population needs and government-backed life science investments. India's market thrives on cost-effective kits for academic use, though quality standardization remains inconsistent. Southeast Asia shows promise with increasing research outsourcing, albeit hampered by logistical limitations. The human ICAM-1 ELISA segment dominates (53% revenue share), with research institutes being the primary end-users.
South America
South America's market is nascent but growing, primarily due to Brazil's expanding pharmaceutical R&D sector. The country contributes over 60% of regional demand, with Argentina following in biomarker research. However, economic instability and currency fluctuations deter consistent imports of high-cost ELISA kits. Local production is minimal, making the region dependent on U.S. and European suppliers. Research applications focus on infectious diseases, leveraging ICAM-1's role in immune response. Political uncertainties and limited healthcare budgets restrict hospital adoption, keeping the market volume below 5% of global share.
Middle East & Africa
This region demonstrates fragmented growth, with Israel and Saudi Arabia leading due to improving healthcare infrastructure. Israel's strong academic research sector utilizes ICAM-1 kits for autoimmune and cancer studies, while GCC countries invest in diagnostic capabilities. South Africa shows moderate demand from university labs. Challenges include limited cold-chain logistics and reliance on imports, inflating costs. The market remains opportunistic, with multinationals like Bio-Techne targeting growth through distributor partnerships. The hospital segment is underpenetrated (<15% share), though increasing privatization could drive future demand.
Report Scope
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Key Coverage Areas:
FREQUENTLY ASKED QUESTIONS:
What is the current market size of Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market?
-> The global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit market was valued at USD 9.7 million in 2024 and is projected to reach USD 15.9 million by 2032.
Which key companies operate in Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market?
-> Key players include Elabscience Biotechnology Inc., LifeSpan BioSciences, Inc, Wuhan Fine Biotech Co., Ltd., CUSABIO, Bio-Techne, Shanghai Korain Biotech Co., Ltd., and MyBiosource, Inc., among others.
What are the key growth drivers?
-> Key growth drivers include increasing research in immunology and inflammation, rising prevalence of chronic diseases, and advancements in ELISA technologies.
Which region dominates the market?
-> North America holds the largest market share, while Asia-Pacific is expected to witness the highest growth rate during the forecast period.
What are the emerging trends?
-> Emerging trends include development of high-sensitivity ELISA kits, automation in diagnostic processes, and increasing adoption in pharmaceutical research.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Overall Market Size
2.1 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size: 2024 VS 2032
2.2 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales: 2020-2032
3 Company Landscape
3.1 Top Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Players in Global Market
3.2 Top Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Companies Ranked by Revenue
3.3 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue by Companies
3.4 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales by Companies
3.5 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Type
3.8 Tier 1, Tier 2, and Tier 3 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Players in Global Market
3.8.1 List of Global Tier 1 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Companies
3.8.2 List of Global Tier 2 and Tier 3 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size Markets, 2024 & 2032
4.1.2 Human
4.1.3 Mouse
4.1.4 Rat
4.1.5 Porcine
4.1.6 Others
4.2 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue & Forecasts
4.2.1 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2025
4.2.2 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2026-2032
4.2.3 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales & Forecasts
4.3.1 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2025
4.3.2 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2026-2032
4.3.3 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
4.4 Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Research Institute
5.1.4 Others
5.2 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue & Forecasts
5.2.1 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2025
5.2.2 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2026-2032
5.2.3 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales & Forecasts
5.3.1 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2025
5.3.2 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2026-2032
5.3.3 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
5.4 Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2024 & 2032
6.2 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue & Forecasts
6.2.1 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2025
6.2.2 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2026-2032
6.2.3 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
6.3 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales & Forecasts
6.3.1 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2025
6.3.2 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2026-2032
6.3.3 By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2032
6.4.2 By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2032
6.4.3 United States Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.4.4 Canada Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.4.5 Mexico Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2032
6.5.2 By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2032
6.5.3 Germany Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.5.4 France Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.5.5 U.K. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.5.6 Italy Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.5.7 Russia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.5.8 Nordic Countries Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.5.9 Benelux Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2032
6.6.2 By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2032
6.6.3 China Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.6.4 Japan Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.6.5 South Korea Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.6.6 Southeast Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.6.7 India Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2032
6.7.2 By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2032
6.7.3 Brazil Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.7.4 Argentina Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, 2020-2032
6.8.3 Turkey Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.8.4 Israel Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.8.5 Saudi Arabia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
6.8.6 UAE Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Elabscience Biotechnology Inc.
7.1.1 Elabscience Biotechnology Inc. Company Summary
7.1.2 Elabscience Biotechnology Inc. Business Overview
7.1.3 Elabscience Biotechnology Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.1.4 Elabscience Biotechnology Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.1.5 Elabscience Biotechnology Inc. Key News & Latest Developments
7.2 LifeSpan BioSciences, Inc
7.2.1 LifeSpan BioSciences, Inc Company Summary
7.2.2 LifeSpan BioSciences, Inc Business Overview
7.2.3 LifeSpan BioSciences, Inc Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.2.4 LifeSpan BioSciences, Inc Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.2.5 LifeSpan BioSciences, Inc Key News & Latest Developments
7.3 Wuhan Fine Biotech Co., Ltd.
7.3.1 Wuhan Fine Biotech Co., Ltd. Company Summary
7.3.2 Wuhan Fine Biotech Co., Ltd. Business Overview
7.3.3 Wuhan Fine Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.3.4 Wuhan Fine Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.3.5 Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
7.4 CUSABIO
7.4.1 CUSABIO Company Summary
7.4.2 CUSABIO Business Overview
7.4.3 CUSABIO Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.4.4 CUSABIO Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.4.5 CUSABIO Key News & Latest Developments
7.5 Bio-Techne
7.5.1 Bio-Techne Company Summary
7.5.2 Bio-Techne Business Overview
7.5.3 Bio-Techne Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.5.4 Bio-Techne Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.5.5 Bio-Techne Key News & Latest Developments
7.6 Shanghai Korain Biotech Co., Ltd.
7.6.1 Shanghai Korain Biotech Co., Ltd. Company Summary
7.6.2 Shanghai Korain Biotech Co., Ltd. Business Overview
7.6.3 Shanghai Korain Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.6.4 Shanghai Korain Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.6.5 Shanghai Korain Biotech Co., Ltd. Key News & Latest Developments
7.7 MyBiosource, Inc.
7.7.1 MyBiosource, Inc. Company Summary
7.7.2 MyBiosource, Inc. Business Overview
7.7.3 MyBiosource, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.7.4 MyBiosource, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.7.5 MyBiosource, Inc. Key News & Latest Developments
7.8 Abbexa
7.8.1 Abbexa Company Summary
7.8.2 Abbexa Business Overview
7.8.3 Abbexa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.8.4 Abbexa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.8.5 Abbexa Key News & Latest Developments
7.9 Boster Biological Technology
7.9.1 Boster Biological Technology Company Summary
7.9.2 Boster Biological Technology Business Overview
7.9.3 Boster Biological Technology Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.9.4 Boster Biological Technology Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.9.5 Boster Biological Technology Key News & Latest Developments
7.10 Biorbyt
7.10.1 Biorbyt Company Summary
7.10.2 Biorbyt Business Overview
7.10.3 Biorbyt Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.10.4 Biorbyt Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.10.5 Biorbyt Key News & Latest Developments
7.11 CLOUD-CLONE CORP.
7.11.1 CLOUD-CLONE CORP. Company Summary
7.11.2 CLOUD-CLONE CORP. Business Overview
7.11.3 CLOUD-CLONE CORP. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.11.4 CLOUD-CLONE CORP. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.11.5 CLOUD-CLONE CORP. Key News & Latest Developments
7.12 Biomatik
7.12.1 Biomatik Company Summary
7.12.2 Biomatik Business Overview
7.12.3 Biomatik Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.12.4 Biomatik Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.12.5 Biomatik Key News & Latest Developments
7.13 Sino Biological, Inc.
7.13.1 Sino Biological, Inc. Company Summary
7.13.2 Sino Biological, Inc. Business Overview
7.13.3 Sino Biological, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.13.4 Sino Biological, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.13.5 Sino Biological, Inc. Key News & Latest Developments
7.14 Assay Genie
7.14.1 Assay Genie Company Summary
7.14.2 Assay Genie Business Overview
7.14.3 Assay Genie Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.14.4 Assay Genie Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.14.5 Assay Genie Key News & Latest Developments
7.15 Abcam
7.15.1 Abcam Company Summary
7.15.2 Abcam Business Overview
7.15.3 Abcam Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.15.4 Abcam Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.15.5 Abcam Key News & Latest Developments
7.16 RayBiotech, Inc.
7.16.1 RayBiotech, Inc. Company Summary
7.16.2 RayBiotech, Inc. Business Overview
7.16.3 RayBiotech, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.16.4 RayBiotech, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.16.5 RayBiotech, Inc. Key News & Latest Developments
7.17 Creative Diagnostics
7.17.1 Creative Diagnostics Company Summary
7.17.2 Creative Diagnostics Business Overview
7.17.3 Creative Diagnostics Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.17.4 Creative Diagnostics Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.17.5 Creative Diagnostics Key News & Latest Developments
7.18 ZodelBiotec Ltd.
7.18.1 ZodelBiotec Ltd. Company Summary
7.18.2 ZodelBiotec Ltd. Business Overview
7.18.3 ZodelBiotec Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Major Product Offerings
7.18.4 ZodelBiotec Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales and Revenue in Global (2020-2025)
7.18.5 ZodelBiotec Ltd. Key News & Latest Developments
8 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Production Capacity, Analysis
8.1 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Production Capacity, 2020-2032
8.2 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Production Capacity of Key Manufacturers in Global Market
8.3 Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Supply Chain Analysis
10.1 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Industry Value Chain
10.2 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Upstream Market
10.3 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit in Global Market
Table 2. Top Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Share by Companies, 2020-2025
Table 5. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales by Companies, (K Units), 2020-2025
Table 6. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Type
Table 9. List of Global Tier 1 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2026-2032
Table 21. By Region � Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2020-2025
Table 25. By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2026-2032
Table 26. By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2020-2025
Table 29. By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2026-2032
Table 30. By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2020-2025
Table 33. By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2026-2032
Table 34. By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2020-2025
Table 37. By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2026-2032
Table 38. By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2020-2025
Table 41. By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, (K Units), 2026-2032
Table 46. Elabscience Biotechnology Inc. Company Summary
Table 47. Elabscience Biotechnology Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 48. Elabscience Biotechnology Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Elabscience Biotechnology Inc. Key News & Latest Developments
Table 50. LifeSpan BioSciences, Inc Company Summary
Table 51. LifeSpan BioSciences, Inc Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 52. LifeSpan BioSciences, Inc Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. LifeSpan BioSciences, Inc Key News & Latest Developments
Table 54. Wuhan Fine Biotech Co., Ltd. Company Summary
Table 55. Wuhan Fine Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 56. Wuhan Fine Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
Table 58. CUSABIO Company Summary
Table 59. CUSABIO Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 60. CUSABIO Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. CUSABIO Key News & Latest Developments
Table 62. Bio-Techne Company Summary
Table 63. Bio-Techne Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 64. Bio-Techne Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Bio-Techne Key News & Latest Developments
Table 66. Shanghai Korain Biotech Co., Ltd. Company Summary
Table 67. Shanghai Korain Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 68. Shanghai Korain Biotech Co., Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Shanghai Korain Biotech Co., Ltd. Key News & Latest Developments
Table 70. MyBiosource, Inc. Company Summary
Table 71. MyBiosource, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 72. MyBiosource, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. MyBiosource, Inc. Key News & Latest Developments
Table 74. Abbexa Company Summary
Table 75. Abbexa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 76. Abbexa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Abbexa Key News & Latest Developments
Table 78. Boster Biological Technology Company Summary
Table 79. Boster Biological Technology Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 80. Boster Biological Technology Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Boster Biological Technology Key News & Latest Developments
Table 82. Biorbyt Company Summary
Table 83. Biorbyt Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 84. Biorbyt Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Biorbyt Key News & Latest Developments
Table 86. CLOUD-CLONE CORP. Company Summary
Table 87. CLOUD-CLONE CORP. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 88. CLOUD-CLONE CORP. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. CLOUD-CLONE CORP. Key News & Latest Developments
Table 90. Biomatik Company Summary
Table 91. Biomatik Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 92. Biomatik Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Biomatik Key News & Latest Developments
Table 94. Sino Biological, Inc. Company Summary
Table 95. Sino Biological, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 96. Sino Biological, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Sino Biological, Inc. Key News & Latest Developments
Table 98. Assay Genie Company Summary
Table 99. Assay Genie Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 100. Assay Genie Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Assay Genie Key News & Latest Developments
Table 102. Abcam Company Summary
Table 103. Abcam Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 104. Abcam Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Abcam Key News & Latest Developments
Table 106. RayBiotech, Inc. Company Summary
Table 107. RayBiotech, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 108. RayBiotech, Inc. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. RayBiotech, Inc. Key News & Latest Developments
Table 110. Creative Diagnostics Company Summary
Table 111. Creative Diagnostics Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 112. Creative Diagnostics Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Creative Diagnostics Key News & Latest Developments
Table 114. ZodelBiotec Ltd. Company Summary
Table 115. ZodelBiotec Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Offerings
Table 116. ZodelBiotec Ltd. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 117. ZodelBiotec Ltd. Key News & Latest Developments
Table 118. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 119. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Capacity Market Share of Key Manufacturers, 2023-2025
Table 120. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Production by Region, 2020-2025 (K Units)
Table 121. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Production by Region, 2026-2032 (K Units)
Table 122. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Opportunities & Trends in Global Market
Table 123. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Drivers in Global Market
Table 124. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Restraints in Global Market
Table 125. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Raw Materials
Table 126. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Raw Materials Suppliers in Global Market
Table 127. Typical Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Downstream
Table 128. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Downstream Clients in Global Market
Table 129. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Product Picture
Figure 2. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Segment by Type in 2024
Figure 3. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Segment by Application in 2024
Figure 4. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue: 2020-2032 (US$, Mn)
Figure 8. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue in 2024
Figure 10. Segment by Type � Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
Figure 21. By Region - Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
Figure 22. By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
Figure 23. By Country - North America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
Figure 24. United States Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
Figure 29. Germany Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 30. France Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales Market Share, 2020-2032
Figure 38. China Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 42. India Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue Market Share, 2020-2032
Figure 44. By Country - South America Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, Market Share, 2020-2032
Figure 45. Brazil Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Sales, Market Share, 2020-2032
Figure 49. Turkey Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Revenue, (US$, Mn), 2020-2032
Figure 53. Global Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit by Region, 2024 VS 2032
Figure 55. Intercellular Adhesion Molecule 1 (ICAM-1/CD54) ELISA Kit Industry Value Chain
Figure 56. Marketing Channels
